Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Alzheimer's Disease

Free Subscription Articles published in Drugs Retrieve available abstracts of 10 articles: HTML format

Single Articles

June 2024
1. HEY JA, Yu JY, Abushakra S, Schaefer JF, et al
   Analysis of Cerebrospinal Fluid, Plasma beta-Amyloid Biomarkers, and Cognition from a 2-Year Phase 2 Trial Evaluating Oral ALZ-801/Valiltramiprosate in APOE4 Carriers with Early Alzheimer's Disease Using Quantitative Systems Pharmacology Model.
   Drugs. 2024 Jun 20. doi: 10.1007/s40265-024-02068.
   PubMed     Abstract available
   
   
   
2. HEY JA, Abushakra S, Blennow K, Reiman EM, et al
   Effects of Oral ALZ-801/Valiltramiprosate on Plasma Biomarkers, Brain Hippocampal Volume, and Cognition: Results of 2-Year Single-Arm, Open-Label, Phase 2 Trial in APOE4 Carriers with Early Alzheimer's Disease.
   Drugs. 2024 Jun 20. doi: 10.1007/s40265-024-02067.
   PubMed     Abstract available
   
   
   September 2023
3. CUMMINGS JL, Osse AML, Kinney JW
   Alzheimer's Disease: Novel Targets and Investigational Drugs for Disease Modification.
   Drugs. 2023 Sep 20. doi: 10.1007/s40265-023-01938.
   PubMed     Abstract available
   
   
   April 2023
4. CUMMINGS J
   Anti-Amyloid Monoclonal Antibodies are Transformative Treatments that Redefine Alzheimer's Disease Therapeutics.
   Drugs. 2023 Apr 15. doi: 10.1007/s40265-023-01858.
   PubMed     Abstract available
   
   
   March 2023
5. HOY SM
   Lecanemab: First Approval.
   Drugs. 2023;83:359-365.
   PubMed     Abstract available
   
   
   April 2022
6. SCHIFANO F, Catalani V, Sharif S, Napoletano F, et al
   Benefits and Harms of 'Smart Drugs' (Nootropics) in Healthy Individuals.
   Drugs. 2022 Apr 2. pii: 10.1007/s40265-022-01701.
   PubMed     Abstract available
   
   
   August 2021
7. DHILLON S
   Aducanumab: First Approval.
   Drugs. 2021;81:1437-1443.
   PubMed     Abstract available
   
   
   July 2021
8. JI C, Sigurdsson EM
   Current Status of Clinical Trials on Tau Immunotherapies.
   Drugs. 2021;81:1135-1152.
   PubMed     Abstract available
   
   
   March 2020
9. SCOTT LJ
   Lemborexant: First Approval.
   Drugs. 2020;80:425-432.
   PubMed     Abstract available
   
   
   
10. SYED YY
    Sodium Oligomannate: First Approval.
    Drugs. 2020;80:441-444.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge.